Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

734 studies match

clinicaltrialsPublishedShowing 101–150 of 734 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05899608	Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients	recruiting	Phase 3	1,600	Summit TherapeuticsINDUSTRY	17	Aug 24, 2026	clinicaltrials
NCT06152575	MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)	recruiting	Phase 3	492	PfizerINDUSTRY	27	Aug 24, 2026